According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence
Exendin-4 Inhibits Glioma Cell Migration, Invasion and Epithelial-to-Mesenchymal Transition Through GLP-1R/Sirt3 Pathway
However, besides several case reports and observational studies, no large clinical trial specifically linking GLP-1 RAs to either increased risk or protection from NAION has been published
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, et al
00:01:45 Don Weinberger: So before we deep dive into these side effect claims, we should briefly review what these meds are and how they work
================== Have you seen metabolic care shift outcomes for your psychiatric patients
